Baxa to Sponsor Los Angeles Symposium on Environmental Exposure and Biological Uptake of Antineopla :: Health-Informant.com

Current articles and info about your health

Thursday, 24th May 2012

home about authors news books xml feed sitemap privacy contact us

There are 12 users online

add to favorites

make home page

Addiction Issues
Aging
Allergies & Sinuses
Alternative Medicine
Beauty & Health
Books & Reading
Common Illnesses
Community Service
Diabetic Health
Dieting
Diseases
Environmental Health
Exercise and Fitness
Health Education
Health Industry
Health Insurance
Health Legal Issues
Health Technology
Healthcare Services
Healthy Eating
Medical Equipment & Products
Men's Health
Mental and Emotional Health
Muscle & Back Pain
Nutrition and Supplements
Pediatrics
Pet Health
Physical Therapy & Massage
Prevention Health
Vision Health
Weight Management
Women's Health

Our Newsletter

Other Resources

For other sources of health news, tips, and information, visit our resources page

Submit an Article

Would you like to have your article posted? Click Here

Baxa to Sponsor Los Angeles Symposium on Environmental Exposure and Biological Uptake of Antineopla
Added: 05/12/2004 Type: Summary Viewed: 1263 time(s) [ Not Rated Yet ]

How would you rate this article: Bad Good Go ť

Printer Friendly Version

Baxa to Sponsor Los Angeles Symposium on Environmental Exposure and Biological Uptake of Antineopla

Baxa Corporation is sponsoring a dinner symposium for pharmacy and nursing professionals to discuss the findings in a recent study from the American Journal of Health-System Pharmacy (AJHP). The symposium will be held Tuesday, May 18th at the W hotel in Los Angeles, CA.

The symposium presents the findings from the study, entitled "Using a Closed-System Protective Device to Reduce Personnel Exposure to Antineoplastic Agents," on biological uptake of cyclophosphamide and ifosfamide in infusion center pharmacy and nursing staff in a newly built cancer center at the University of Utah. The presenter, Jim Jorgenson, RPh, is Director of Pharmacy for the Huntsman Cancer Institute, where the study took place.

Study data documented that standard worker precautions and safe handling guidelines were not effective in preventing environmental exposure and subsequent uptake of the chemotherapy drugs in the healthcare workers tested. These findings have been supported in a NIOSH Alert entitled, "Preventing Occupational Exposures to Antineoplastic and other Hazardous Drugs in Healthcare Settings" published last month to the Centers for Disease Control (CDC) Web site.

The clinicians who authored the study demonstrated biological uptake of the two drugs tested through urine studies with pharmacy and nursing personnel. Additionally, wipe samples of selected facility and equipment surfaces yielded positive results for all samples.

Following these baseline tests, the PhaSeal closed-loop drug containment system was implemented in the chemotherapy infusion center, while workers continued the preparation and administration safeguards already in use. Six months following the adoption of the PhaSeal System, the presence of the two drugs originally detected in urine samples from center personnel had been reduced to undetectable levels. The study also showed that drug contamination initially detected on infusion center surfaces was significantly reduced following implementation of the PhaSeal System.

The complimentary symposium will be held Tuesday, May 18th at the W hotel of Los Angeles, CA, beginning at 5:30 PM. Participants are eligible for one credit hour of Continuing Education (CEU).

Article Pages: 1

Article Comments

Add Comment |

View All (0)

There are currently no comments for this article.

Advanced Search


Good Resources
Create a Happier Life High Protein, Low Cal Food Martial Arts Reviews Affiliate With Us